Myopia at Age 12
What to Expect and What to Do

Short answer: By age 12, most children have had myopia for several years. The focus at this stage shifts to: how fast is it still progressing, what is the projected adult prescription, and is the current management approach (if any) working? The fastest growth phase is ending, but progression can continue significantly into the mid-teens.

Current growth phase at age 12: Moderating growth phase — 0.12–0.22mm/year typical; slowing compared to age 8–10

Clinical picture: what this age means for myopia

The axial growth rate peaks in the early school years and decelerates progressively. By age 12, growth is typically 30–40% slower than at age 8. However, for fast progressors, even this reduced rate can add 1–2mm of axial length by the time stabilisation occurs. Assessment of progression rate with at least two measurements is essential to determine management intensity.

What parents should do now

Treatment options at age 12

Management remains effective through this age and into the mid-teens. If not yet started and child is progressing >0.50D/year, starting now still produces meaningful cumulative benefit by the time stabilisation occurs.

See your child's projected prescription at age 18

Enter current age, axial length, and a prior measurement. Get projected adult prescription with and without treatment — in under 60 seconds.

Project myopia progression →
Free · No login · Under 30 seconds

How age at onset predicts lifetime risk

Age myopia startsYears of fast growth remainingHigh myopia risk (without treatment)
Age 6~12 yearsVery high (est. 60–80%)
Age 7~11 yearsVery high (est. 55–75%)
Age 8~10 yearsHigh (est. 45–65%)
Age 9~9 yearsHigh (est. 35–55%)
Age 10~8 yearsModerate–High (est. 25–45%)
Age 12~6 yearsModerate (est. 15–30%)
Age 14~4 yearsLower (est. 10–20%)
Age 16~2 yearsLow (est. 5–12%)

High myopia defined as ≥−6.00D. Risk estimates based on Tideman 2018 longitudinal data; individual outcomes vary substantially. Your row is highlighted.

Sources: Tideman JWL et al. Acta Ophthalmologica. 2018;96(3):301–309 (normative AL curves, age at onset) · Sanz Diez P et al. Ophthalmic Physiol Opt. 2019 (meta-analysis, onset age) · IMI 2025 Digest — Tahhan N et al. · Donovan L et al. Ophthalmic Physiol Opt. 2012;32(3):240–247 (stabilisation data) · Chamberlain P et al. Optom Vis Sci. 2019 (MiSight RCT, age 8+) · Bao J et al. JAMA Ophthalmol. 2022 (Stellest RCT)

This page is for educational purposes and does not constitute medical advice. Diopter-to-axial-length conversions are approximations (±2–3D individual variation). MyopiaTracker is a decision-support tool — not a diagnostic device. Consult a qualified optometrist or ophthalmologist for personalised advice.